Turn Therapeutics Inc. 8-K

What Happened

• On July 7, 2026, Turn Therapeutics Inc. filed a Current Report on Form 8‑K (Accession No. 0001213900-26-075757) to disclose a press release and an updated investor presentation under Item 7.01 (Regulation FD Disclosure). The press release and investor presentation are furnished as Exhibits 99.1 and 99.2 to the filing.

Key Details

• Filing date: July 7, 2026; Accession No.: 0001213900-26-075757.
• Exhibits furnished: 99.1 (Press Release, dated July 7, 2026) and 99.2 (Investor Presentation, dated July 7, 2026).
• The Form 8‑K lists Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Exhibits), including the Inline XBRL cover page (Exhibit 104).
• The filing does not report earnings, executive changes, or other Item-coded events.

Why It Matters

• This filing signals that Turn Therapeutics publicly released new investor-facing materials on July 7, 2026. Under Regulation FD, the company is making information broadly available to investors at the same time. Retail investors should review the attached press release and investor presentation for any material updates (e.g., clinical, strategic, or financial information) that could affect the company’s outlook.